People channel feed

As­traZeneca reshuf­fles Chi­na lead­er­ship, sets up bio­phar­ma group to mir­ror glob­al struc­ture

Last year
China
Pharma

Reagent mak­er Al­pha Tekno­va cuts 15% of work­ers, ter­mi­nates com­mer­cial, peo­ple ex­ec roles amid down­turn

Last year
Manufacturing

Lon­za to shut­ter Cal­i­for­nia mam­malian clin­i­cal fa­cil­i­ty and lay off 218 staffers

Last year
Manufacturing

Al­lakos halves work­force, drops lead in­flam­ma­to­ry pro­gram

Last year
R&D

Up­dat­ed: Vivek Ra­maswamy gives up pres­i­den­tial bid, en­dors­es Trump, no plans to re­turn to Roivant

Last year

Bio­Mar­in's chief com­mer­cial of­fi­cer step­ping down, search for suc­ces­sor be­gins

Last year
Pharma

The Bell Labs of biotech: Stu­art Schreiber has bil­lion­aire sup­port for new bio­med­ical in­sti­tute 

Last year
Startups

Ver­tex founder Joshua Boger on sur­viv­ing down­turns, 'painful' part­ner­ships, and the im­por­tance of cul­ture: #JPM24

Last year
Startups

Ex-Cel­gene chief Mark Alles, for­mer Goldfinch Bio leader Tony John­son are back in the game as CEOs

Last year
Peer Review

C4 Ther­a­peu­tics cuts staff, re­struc­tures to fo­cus on lead pro­tein degra­da­tion pro­grams, dis­cov­ery pacts

Last year
R&D

El­liot­t's Marc Stein­berg sees more health­care in­vest­ments for the some­times-ac­tivist firm this year: #JPM24

Last year
Financing

Ex­elix­is cuts 175 staffers to pri­or­i­tize late-stage drug de­vel­op­ment   

Last year
R&D

Af­fimed cuts up to 50% of em­ploy­ees to sup­port clin­i­cal projects, CEO de­parts

Last year
R&D

AlloVir lays off 95% of staffers af­ter shut­ter­ing PhI­II an­tivi­ral cell ther­a­py tri­als 

Last year
R&D

Evotec CEO Wern­er Lan­thaler re­signs; Af­ter No­vo deal, ex-For­ma chief ush­ers in new era at Paci­ra

Last year
Peer Review

In­tel­lia Ther­a­peu­tics cuts 15% of work­force, ex­tends cash run­way in­to mid-2026

Last year
R&D

Feng Zhang's CRISPR start­up Aera shrinks head­count by a quar­ter

Last year
Startups

Up­dat­ed: Delfi Di­ag­nos­tics hires Il­lu­mi­na’s chief com­mer­cial of­fi­cer as next CEO

Last year
Diagnostics

Ther­mo Fish­er to shut­ter Petaluma man­u­fac­tur­ing fa­cil­i­ty, lay off 74 staffers by Feb­ru­ary

Last year
Manufacturing

Scoop: Re­silience re­ceives Form 483 due to mold at Cana­di­an site, more lay­offs an­tic­i­pat­ed

Last year
FDA+
Manufacturing

Ex­clu­sive: Roger Perl­mut­ter on the biggest prob­lem in Big Phar­ma, leav­ing Mer­ck, and build­ing Eikon

Last year
Startups
R&D

Bio­Marin strikes co­op­er­a­tion deal with ac­tivist in­vestor El­liott, sets up re­view com­mit­tee and adds board mem­bers

Last year
Pharma

Scoop: Re­silience down­sizes tech­ni­cal R&D and qual­i­ty as­sur­ance di­vi­sions

Last year
Manufacturing

Aclaris halves head­count, banks on next mid-stage read­out af­ter clin­i­cal set­backs tanked shares

Last year
First page Previous page 15161718192021 Next page Last page
A service from the Financial Times